About
Technology
Issues
FAQ
Links
Official Page
Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.
site/software ©
exaly
; All materials licenced under
CC by-SA
.